Chemoinformaics analysis of Tetradecyl 13-methylpentadecanoate
| Molecular Weight | 452.808 | nRot | 26 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 0 |
| Exact Molecular Weight | 452.459 | nRing | 0 |
| Solubility: LogS | -5.417 | nHRing | 0 |
| Solubility: LogP | 5.108 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 92 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 91.7116 |
| nHD | 0 | BPOL | 62.7964 |
| QED | 0.549 |
| Synth | 2.507 |
| Natural Product Likeliness | 0.468 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.399 |
| Pgp-sub | 0.001 |
| HIA | 0.124 |
| CACO-2 | -4.501 |
| MDCK | 0.0000119 |
| BBB | 0.764 |
| PPB | 0.956381 |
| VDSS | 2.381 |
| FU | 0.0964113 |
| CYP1A2-inh | 0.415 |
| CYP1A2-sub | 0.891 |
| CYP2c19-inh | 0.355 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.164 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.691 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.186 |
| CL | 7.726 |
| T12 | 0.284 |
| hERG | 0.035 |
| Ames | 0.02 |
| ROA | 0.109 |
| SkinSen | 0.436 |
| Carcinogencity | 0.112 |
| EI | 0.967 |
| Respiratory | 0.583 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.683429 |